Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Their new facility, Wesley Pharmaceuticals, further enhances capacity, ensuring consistent supply for growing demands
Glucagon receptor agonists Co-agonist and multi-agonist synthetic incretin-based peptides incorporating GCGR agonism are now advancing in pharmaceutical pipelines
According to a report by Forbes, sales of the drug have doubled every year since its launch in 2018, making it one of the fastest-growing diabetes medications on the market
doi: 10.2337/dc10-1333 12
Reliable temperature control is essential for preserving the medications potency
US$ 22.10
US$ 25.37
US$ 29.00
US$ 22.33
US$ 25.42
